General Announcement::ASX:TLX; Nasdaq:TLX - Presentation to Accompany Biologics Platform Acquisition

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
13-Jan-2025 05:36:11
Status
New
Announcement Sub Title
ASX:TLX; Nasdaq:TLX - Presentation to Accompany Biologics Platform Acquisition
Announcement Reference
SG250113OTHRRQFS
Submitted By (Co./ Ind. Name)
Genevieve Ryan
Designation
Company Secretary
Effective Date and Time of the event
13/01/2025 17:00:00
Description (Please provide a detailed description of the event in the box below)
ASX:TLX; Nasdaq:TLX - Presentation to Accompany Biologics Platform Acquisition

Attachments

20250113 Project Insight Asset Deck vFINAL.pdf
Total size =883K